US 11931343
CD73 inhibitors
granted A61KA61K31/282A61K31/4192
Quick answer
US patent 11931343 (CD73 inhibitors) held by Arcus Biosciences, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/282, A61K31/4192, A61K31/422, A61K31/423